Severe coronavirus-2 infection background for cardiovascular complications
DOI:
https://doi.org/10.5281/zenodo.10711339Keywords:
Systemic Inflammatory Response Syndrome, Heart Disease Risk Factors, COVID-19Abstract
Background: Covid-19 infection can affect the cardiovascular system in the long term, due to the inflammation and endothelial damage caused by SARS-CoV-2. It is unknown whether patients who have had severe covid-19 have a higher risk of cardiovascular complications than those who have not.
Objective: To compare the presentation of cardiovascular complications in patients with a history of severe SARS-CoV-2 infection and population without this history.
Material and methods: An observational analytical cohort study was conducted that included 988 patients, with a calculation for the sample size to detect a minimum RR of 1.5 with a statistical power of 80%. The outcome was measured through electronic medical records and variables were compared. A descriptive analysis was performed using measures of central tendency and dispersion for quantitative variables and absolute and relative frequencies for qualitative variables.
Results: The history of severe covid-19 infection is related to a higher risk of rehospitalization for cardiovascular causes. There was an increase in the frequency of endocarditis, arrhythmias and thrombotic events. Type 4a infarcts and thrombi in the right atrium were more common in patients with covid-19.
Conclusions: Covid-19 was associated with a higher hospital readmission for cardiac problems, such as endocarditis and arrhythmias. A persistent negative impact on long-term cardiovascular health was identified in these patients.
Downloads
References
Mendis S, Puska P, Norrving B. Global atlas on cardiovascular disease prevention and control. WHO. 78-92-4-156437-3, 2011.
World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. Geneva: World Health Organization; 2013. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/94384/9789243506236_spa.pdf.
Borrayo G, Rosas M, Ramírez E, et al. STEMI and NSTEMI: Real-world Study in Mexico (RENASCA). Arch Med Res. 2018:49(8):609-619.
Instituto Nacional de Estadística y Geografía. Características de las defunciones registradas en México durante enero a agosto de 2020. Comunicado de prensa núm. 61/21. 27 de enero de 2021. Disponible en: https://www.inegi.org.mx/contenidos/saladeprensa/boletines/2021/EstSociodemo/DefuncionesRegistradas2020_Pnles.pdf.
Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020;(3):230-232.
Parohan M, Yaghoubi S, Seraji A. Cardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies. Eur Heart J Acute Cardiovasc Care. 2020;9(6):665-677.
Crook H, Raza S, Nowell J, et al. Long covid—mechanisms, risk factors, and management BMJ 2021;(1648):374.
Russo V, Bottino R, Carbone A, et al. COVID-19 and Heart: From Clinical Features to Pharmacological Implications. J Clin Med. 2020;9(6):1944.
Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265-1273.
Chilazi M, Duffy EY, Thakkar A et al. COVID and Cardiovascular Disease: What We Know in 2021. Curr Atheroscler Rep. 23, 37 (2021).
Abbasi J. The COVID Heart—One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks. JAMA. 2022;327(12):1113-1114.
Rajpal S, Tong MS, Borchers J, et al. Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection. JAMA Cardiol. 2021;6(1):116-118.
Vallejo-Camazón N, Teis A, Martínez-Membrive MJ, et al. Long COVID- 19 and microvascular disease-related angina. Rev Esp Cardiol (Engl Ed). 2022;75(5):444-446.
Xie Y, Xu E, Bowe B, et al. Long-term cardiovascular outcomes of COVID-19. Nature Medicine. 2022;(28):583-590.
Xiong TY, Redwood S, Prendergast B, et al. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J. 2020;41(19):1798-1800.
Raman B, Bluemke DA, Lüscher TF, et al. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43(11):1157-1172.
Corrales-Medina VF, Taljaard M, Yende S, et al. Intermediate and long- term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults. Am Heart J. 2015;170(2):306-312.
Metkus TS, Sokoll LJ, Barth AS, et al. Myocardial Injury in Severe COVID-19 Compared With Non-COVID-19 Acute Respiratory Distress Syndrome. Circulation. 2021;143(6):553-565.
Liberale L, Montecucco F, Schwarz L, et al. Inflammation and cardiovascular diseases: lessons from seminal clinical trials. Cardiovasc Res. 2021;117(2):411-422.
Tardif JC, Kouz S, Waters DD, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med. 2019;381(26):2497-2505.
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.
García-Esquivel MA, Huerta-Liceaga F, Martínez-Garzón LA, et al. Infarto agudo al miocardio con elevación del segmento ST en época de COVID-19. Rev Med Inst Mex Seguro Soc. 2020;58 Supl 2:S268-281.
Espriu-Romero DF, Hernández-González MA, Solorio-Meza SE. Mortalidad asociada a daño miocárdico mediante troponina I en pacientes con COVID-19. Arch Cardiol Mex. 2021;91(1):1-8.
Raisi-Estabragh Z, Cooper J, Salih A, et al. Cardiovascular disease and mortality sequelae of COVID-19 in the UK. BiobankHeart. 2023;109:119-126.
Katsoularis I, Fonseca-Rodríguez O, Farrington P, et al. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet. 2021;398:599-607.
Zuin M, Rigatelli G, Roncon L, et al. Risk of incident heart failure after COVID-19 recovery: a systematic review and meta-analysis. Heart Fail Rev. 2022;27:1-6.
Pimentel M, Magalhães APA, Novak CV, et al. Cardiac Arrhythmias in Patients with COVID-19. Arq Bras Cardiol. 2021;117(5):1010-1015.
Harrison SL, Buckley BJR, Rivera-Caravaca JM, et al. Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews. Eur Heart J Qual Care Clin Outcomes. 2021;7(4):330-339.
Ayoubkhani D, Khunti K, Nafilyan V, et al. Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study. BMJ. 2021;372:n693.
Akhtar Z, Trent M, Moa A, et al. The impact of COVID-19 and COVID vaccination on cardiovascular outcomes. Eur Heart J Suppl. 2023;25(Suppl A):A42-A49.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Revista Médica del Instituto Mexicano del Seguro Social
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.
